KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Neogenomics (NEO) over the last 17 years, with Q4 2025 value amounting to $983.5 million.

  • Neogenomics' Non-Current Assets fell 561.17% to $983.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $983.5 million, marking a year-over-year decrease of 561.17%. This contributed to the annual value of $983.5 million for FY2025, which is 561.17% down from last year.
  • As of Q4 2025, Neogenomics' Non-Current Assets stood at $983.5 million, which was down 561.17% from $992.3 million recorded in Q3 2025.
  • Over the past 5 years, Neogenomics' Non-Current Assets peaked at $1.2 billion during Q3 2021, and registered a low of $551.7 million during Q1 2021.
  • Moreover, its 5-year median value for Non-Current Assets was $1.1 billion (2023), whereas its average is $1.1 billion.
  • In the last 5 years, Neogenomics' Non-Current Assets soared by 12308.63% in 2021 and then tumbled by 561.17% in 2025.
  • Neogenomics' Non-Current Assets (Quarter) stood at $1.2 billion in 2021, then fell by 4.5% to $1.1 billion in 2022, then fell by 4.44% to $1.1 billion in 2023, then fell by 3.91% to $1.0 billion in 2024, then fell by 5.61% to $983.5 million in 2025.
  • Its Non-Current Assets was $983.5 million in Q4 2025, compared to $992.3 million in Q3 2025 and $1.0 billion in Q2 2025.